Publisher's Synopsis
In the dynamic realm of modern medicine, we stand at a pivotal juncture where the convergence of disease, drugs, and patient individuality is shaping a new paradigm. The field is transitioning from traditional drug development towards personalized therapeutic strategies tailored to the unique physiology of each person. Over past decades, significant progress in preventive measures, diagnostic techniques, and treatment approaches has greatly improved patient care. However, the successful implementation of personalized medicine hinges on a thorough understanding of pathogenesis, therapeutic agents, biochemical mechanisms, drug interactions, and patient-specific factors.
In this context, the objective of this reprint, "Emerging Strategies in Drug Development and Clinical Care in the Era of Personalized and Precision Medicine", is to provide a comprehensive collection of the latest research, showcasing the current state of knowledge and forecasting future trends in drug development and clinical practice. This reprint emphasizes the importance of understanding biochemical mechanisms of action, innovative drug formulations, and robust preclinical and clinical evaluations, including efficacy, pharmacokinetics, and toxicity, all within the framework of precision and personalized medicine.
